Free Access
Med Sci (Paris)
Volume 26, Number 11, Novembre 2010
Page(s) 976 - 980
Section Resistance aux antibiotiques : un enjeu international
Published online 15 November 2010
  1. British Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. British Medical Journal 1948 ; 2 : 769-83. [Google Scholar]
  2. World Health Organisation. Anti-tuberculosis drug resistance in the world : fourth global report. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 2008, Genève, 142. [Google Scholar]
  3. European Center for Disease Prevention and Control, WHO Regional Office for Europe : Tuberculosis surveillance in Europe 2008, 2010, Stockholm. [Google Scholar]
  4. Khuê PM, Truffot-Pernot C, Texier-Maugein J, et al. A 10-year prospective surveillance of mycobacterium tuberculosis drug resistance in France 1995-2004. Eur Respir J 2007 ; 30 : 937-44. [Google Scholar]
  5. World Health Organisation. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response 2010, Genève, 71. [Google Scholar]
  6. Chan ED, Laurel V, Strand MJ, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004 ; 169 : 1103-9. [Google Scholar]
  7. Flament-Saillour M, Robert J, Jarlier V, Grosset J. Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study. Am J Respir Crit Care Med 1999 ; 160 : 587-93. [Google Scholar]
  8. Uffredi ML, Truffot-Pernot C, Dautzenberg B, et al. An intervention programme for the management of multidrug-resistant tuberculosis in France. Int J Antimicrob Agents 2007 ; 29 : 434-9. [Google Scholar]
  9. Center for Disease Control and Prevention. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. MMWR Recomm Rep 2009 ; 58 : 1-43. [Google Scholar]
  10. Center for Disease Control and Prevention. Emergence of mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000- 2004. MMWR Morb Mortal Wkly Rep 2006 ; 55 : 301-5. [Google Scholar]
  11. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006 ; 368 : 1575-80. [Google Scholar]
  12. Kliiman K, Altraja A. Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB. Eur Respir J 2009 ; 33 : 1085-94. [Google Scholar]
  13. Veziris N, Martin C, Brossier F, et al. Treatment failure in a case of extensively drug-resistant tuberculosis associated with selection of a GyrB mutant causing fluoroquinolone resistance. Eur J Clin Microbiol Infect Dis 2007 : 26 : 423-5. [Google Scholar]
  14. Diacon AH, Pym A, Grobusch M, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 2009 ; 360 : 2397-405. [Google Scholar]
  15. Ibrahim M, Truffot-Pernot C, Andries K, et al. Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis. Am J Respir Crit Care Med 2009 ; 180 : 553-7. [Google Scholar]
  16. Escudero E, Peña JM, Alvarez-Sala R, et al. Multidrug-resistant tuberculosis without HIV infection: success with individualised therapy. Int J Tuberc Lung Db 2006 ; 10 : 409-14. [Google Scholar]
  17. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. Jama 1993 ; 270 : 65-8. [Google Scholar]
  18. Brossier F, Veziris N, Jarlier V, Sougakoff W. Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid. Int J Tuberc Lung Dis 2009 ; 13 : 260-5. [Google Scholar]
  19. Frieden TR, Sherman LF, Maw KL, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. Jama 1996 ; 276 : 1229-35. [Google Scholar]
  20. World Health Organisation. Guidelines for the programmatic management of drug-resistant tuberculosis 2008, Genève. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.